Original ArticleThe Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Section snippets
Methods
We performed this study in accordance with The Cochrane Handbook for Systematic Reviews of Interventions32 and reported findings following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.33 The protocol was registered on PROSPERO under CRD42020201298.
Results
The initial search returned 3368 unique citations, and 117 full texts were reviewed. Of these, 15 records met our inclusion criteria. Supplemental Figure 1 shows a detailed Preferred Reporting Items for Systematic Reviews and Meta-analyses flow diagram.
Discussion
The present analysis is the most comprehensive systematic review conducted to date to investigate the effects of bariatric surgery on DR. Our findings suggest that the risk of having any DR for patients who underwent bariatric surgery was 83% lower than that of nonsurgical patients during follow-up. Bariatric surgery also significantly reduced the prevalence of STDR by 53% during follow-up when compared with nonsurgical patients. In addition, 71% fewer patients who had undergone surgery had
Conclusions
The risks of DR and STDR development were significantly lower in patients who were obese with T2DM who underwent bariatric surgery compared with those did not undergo surgery. In addition, severity of DR at baseline was an important sign of early worsening of DR postoperatively, suggesting the need for early vigilant DR screening for patients with existing STDR who undergo bariatric surgery. Ultimately, bariatric surgery resulted in a reduced rate of progression of DR compared with nonsurgical
References (49)
- et al.
Diabetic retinopathy
Lancet
(2010) - et al.
The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: a retrospective cohort study
Surg Obes Relat Dis
(2016) - et al.
Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients
Surg Obes Relat Dis
(2019) - et al.
Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30–35
Surg Obes Relat Dis
(2020) - et al.
Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus
J Am Coll Surg
(2013) - et al.
Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
Lancet
(2015) - et al.
Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese
Surg Obes Relat Dis
(2016) - et al.
Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study
J Diabetes Complications
(2014) - et al.
Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes
Diabetes Metab
(2018) - et al.
Bariatric surgery is associated with less progression of diabetic retinopathy: a systematic review and meta-analysis
Surg Obes Relat Dis
(2017)
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
Ophthalmology
Diabetic retinopathy: a position statement by the American Diabetes Association
Diabetes Care
Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
Clin Exp Ophthalmol
Bariatric surgery: a systematic review and meta-analysis
JAMA
Long-term outcomes of bariatric surgery: a national institutes of health symposium
JAMA Surg
Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications
JAMA
Roux-en-Y gastric bypass could slow progression of retinopathy in type 2 diabetes: a pilot study
Obes Surg
Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes
Diabetes Metab Res Rev
Diabetic retinopathy in people with Type 2 diabetes and obesity treated by Roux-en-Y gastric bypass compared with non-operated controls: with focus on the role of diabetes remission in a cross-sectional and a 6-year follow-up study
Diabet Med
Type 2 diabetes mellitus and microvascular complications 1 year after roux-en-Y gastric bypass: a case–control study
Diabetologia
Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care
Ann Intern Med
Incidence of diabetes mellitus, cardiovascular diseases, and cancer in patients undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) vs medical treatment
Obes Surg
Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes
N Engl J Med
Bariatric surgery might aggravate proliferative diabetic retinopathy
Acta Ophthalmol
Cited by (20)
Nonpharmacological, pharmacological, and surgical options for obesity-related cardiometabolic disorders
2024, Insulin: Deficiency, Excess and Resistance in Human DiseaseDiabetic Disease of the Eye in Canada: Consensus Statements from a Retina Specialist Working Group
2024, Ophthalmology and TherapyImpact of Bariatric Surgery on Treatment Burden and Progression of Diabetic Retinopathy
2024, Journal of VitreoRetinal DiseasesDiabetic retinopathy and maculopathy
2023, Diabetologie und Stoffwechsel
Supplemental Material available at AJO.com.